Fear for pharma growth prospects

Genomics identified as most impactful pharma trend

Pharma voted second most trusted industry in Britain

Moderna becomes latest ABPI member

HBA names 2023 Woman of the Year

Potential blockbuster drug front runners highlighted

ROI in R&D declines sharply in 2022

RSV drug nirsevimab chases FDA approval

Spoonful of technology

Prescribing habits shift noted in IBD

A new moonshot for rare diseases

Spotlight: October-November 2022

Landmark approval for first haemophilia B gene therapy

Urgent need to boost trade for UK's life sciences, says ABPI

2022 Access to Medicine Index reveals improvement

Pharma's sustainability agenda centre stage in new ABPI report

First paediatric pneumococcal vaccine approved for 10 years

New climate action announced by pharma CEOs

Global health agencies collaborate to ease Ebola outbreak

Thermo Fisher sponsorship supports future STEM workforce